Oct. 23 at 7:40 PM
$PRCT I see some insightful questions posted on last SA article. Sharing for bulls to share their thoughts.
1) why the YoY revenue growth falling down, when the hospital penetration rate is just 20%? It estimates only 45% growth for 2025-26 for handpieces (DOWN from 65% growth of this year), and 10% growth for the Hydros systems.
If anything, doesn't it reflect poor management to scale business YoY at similar or even higher rate when only 20% hospitals have the systems setup? There are 400,000 BPH surgeries a year in US alone, so PRCT is only ~10% share of current US TAM.
If Aquablation technology is indeed a superior solution overall, should not the growth to accelerate with more systems setup, and more patients willing to chose Aquablation?
2) There were 59% YoY handpieces growth and 49% YoY Hydros base growth in the US. Then why the total US revenue growth only 46%?
It seems reflecting YoY ASP growth have been lower in Q2 2025 than Q2 2024. Otherwise should not the growth be in 50-55%?
